ReWalk Exoskeleton Study Confirmed Long-Term Safety
A peer-reviewed study verified that the personal exoskeleton allows for safe, long-term use at home.
Updated on Oct. 14, 2026 in Stroke
Live Poll
Do you trust that new medical robotics will significantly improve the daily lives of patients?
A recent peer-reviewed study confirmed the long-term safety and usage patterns of the ReWalk 6.0 Personal Exoskeleton. Participants reported improvements in quality of life, pain levels, and bowel and bladder management.
Why it matters
Researchers conducted this study to evaluate how spinal cord injury patients use exoskeleton devices safely outside of controlled clinical settings. The findings highlight the potential for long-term mobility assistance in home environments.
Participants achieved a median walking speed of 0.43 meters per second and a median distance of 129 meters in six-minute tests. The device received a median System Usability Scale score of 70 out of 100.
The players
Centro Protesi Inail
This is the research institution in Italy where the study on exoskeleton usage was conducted.
Lifeward
This is the company that produces the ReWalk Personal Exoskeleton, with operations in Massachusetts, Israel, and Germany.
The details
Seven individuals with chronic paraplegia utilized the ReWalk 6.0 Personal Exoskeleton at home after receiving structured training. Researchers monitored the subjects for periods ranging from 20 to 45 months, noting no exoskeleton-related fractures or falls.
Timeline
October 14, 2026: The peer-reviewed study results were published.
Health Landscape
This study contributes to the evolution of medical science by shifting the clinical focus from short-term laboratory performance to real-world home functionality. It benchmarks the performance of modern wearable robotics against established standards for rehabilitation and patient quality of life.
The study demonstrates that users can safely integrate exoskeleton technology into their daily home routines. These results suggest that long-term usage may provide tangible benefits to bowel and bladder management and overall pain levels.
The takeaway
Reliable data now supports the long-term viability of personal exoskeleton use for individuals with chronic paraplegia. Patients interested in this technology should consult with their medical providers to assess if their physical profile matches the criteria used in the study.
Further reading
Learn more about advancements in mobility and recovery at Stroke.
Live Poll
Do you trust that new medical robotics will significantly improve the daily lives of patients?
